Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice
about
Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationIs the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisMonocytes in myocardial infarctionCholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosisFibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse modelsAnti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cellsInhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expressionThe protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genesMembrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2.Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particlesMale-specific association between a gamma-secretase polymorphism and premature coronary atherosclerosis.25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetesInflammation and its resolution as determinants of acute coronary syndromes.Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiencyChanging concepts of atherogenesis.Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis.Monocytes: protagonists of infarct inflammation and repair after myocardial infarctionSR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation.Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.Effects of G-CSF on serum cholesterol and development of atherosclerotic plaque in apolipoprotein E-deficient micePeroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesionsMonocyte accumulation in mouse atherogenesis is progressive and proportional to extent of diseaseVascular effects of GI262570X (PPAR-gamma agonist) in the brown adipose tissue of Han Wistar rats: a review of 1-month, 13-week, 27-week and 2-year oral toxicity studies.Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataMacrophages retain hematopoietic stem cells in the spleen via VCAM-1ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature.Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain.Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.Vitamin D receptor signaling inhibits atherosclerosis in miceOmega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.Donor and recipient cell surface colony stimulating factor-1 promote neointimal formation in transplant-associated arteriosclerosisHeterogeneity of human macrophages in culture and in atherosclerotic plaquesInitiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?Disordered haematopoiesis and athero-thrombosis.Cytokines and atherosclerosis: a comprehensive review of studies in mice
P2860
Q21558503-38AAFC86-1C93-4E91-A929-8C01456B056AQ26746659-F8760975-A1A6-4423-A0D9-88448BA4B485Q26827070-D2553176-F506-4EC0-844D-65692FAC93E2Q26861206-734DEF56-65DE-4DEC-801A-40C0D62C5205Q26994661-94D66B61-F0A7-41BC-8AE4-43734FCCF025Q27012536-36CD090E-8B0C-4890-B42C-05D4D7BC4789Q28365595-D02746DA-4030-4290-9B83-81CF2FC69609Q28594304-843FE0C1-82BE-4B0B-84B6-CA75D1DB90EAQ30438474-23AC4764-9D53-4286-A6B0-E9735381D9AFQ30587665-E7FBDEC1-72C1-4AF1-B2C3-2A9487F5F0B9Q33382990-539E4596-53AB-43AF-B0EF-3243096F5C43Q33632511-016F3E35-2B43-4F27-AC51-06EEAECEA6CBQ33834800-7884435B-2BF1-44DA-B11A-FA40D55C6054Q33881232-C139F0E2-59B5-4A54-BE1C-502EEE83B1D5Q33890391-95B6B97A-40C9-45B0-AD85-D01A0D4F2C86Q33902070-C58FD3B1-7030-460D-B485-69B1E254F9E4Q33942337-8D1AACB0-D7F5-41AA-B3AA-CE507B3C17B3Q33953899-CA30A650-3189-47F3-B54E-481C5CD933DEQ33976385-43F53EF9-2E1A-4279-A020-8A8E1DADFE34Q34028934-D4199F63-D6AE-44CA-8056-523F76760F97Q34167012-D29CE8BC-216F-46B2-BCCE-6B117D79C294Q34290988-64D9958B-C096-4D8C-AFB0-84C2DF200461Q34457373-850C80E7-1177-46BE-B256-36ACBC84EC8DQ34772143-7437DE3F-14AA-4CA5-9433-12455791189FQ34790065-8A50E821-959A-4718-81E8-0869ABC52B38Q35251005-E7CCAB2D-5D60-4353-99B4-B2441098FBF6Q35289180-89240159-7167-4811-A1B5-9FFF5C78D3C5Q35370268-76319E32-8A67-42FD-98CA-309C8F7EEC96Q35640438-9BD4FC18-E52E-4ED7-8959-095B1164FCA4Q35848839-ABE278E2-8C47-48E9-97A0-6147FA64EE6EQ35849325-4CA408A1-B2A6-4BEE-8C8A-0B9CE2235366Q35952700-5EE8571C-70AD-4D3B-991C-70A1D66FF40BQ36065512-CAB61300-9B7D-4545-86AF-2F4E1015AE8DQ36200739-60D2C408-04B0-41A0-98D2-A066F0F60685Q36422755-28B2556C-7FE1-4B47-9828-C6B61CCAFA3CQ36472831-CB386B9D-BAB8-4D41-8EBA-B7B2CD877367Q36512340-5BE59C8D-D01B-46EC-BC1D-778D9CFD71B8Q36681348-FF897CDA-668D-48AB-A2AE-5218F6DDC9CDQ36773876-E00C6557-E42E-4137-B642-F1E387DF9884Q36802942-B6549A7F-210B-4219-921E-BC67818F2F78
P2860
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@ast
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@en
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@nl
type
label
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@ast
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@en
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@nl
prefLabel
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@ast
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@en
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@nl
P2093
P2860
P3181
P356
P1476
Heterozygous osteopetrotic (op ...... n LDL receptor- deficient mice
@en
P2093
A Loussararian
J Tripathi
S Tripathi
T Rajavashisth
P2860
P304
P3181
P356
10.1172/JCI119891
P407
P577
1998-06-15T00:00:00Z